MedTrace Logo

Long Term Prospective Study Evaluating Effectiveness of Narrow Margins for Low-Risk Head and Neck Basal Cell Carcinomas

NCT01903239 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 179

Last updated 2016-02-05

No results posted yet for this study

Summary

The purpose of this study is to determine the narrowest excision margin for head and neck Basal Cell Carcinoma (BCC) tumors satisfying the National Comprehensive Cancer Network® (NCCN) low-risk for recurrence clinical and histopathological criteria that gives an acceptable (95%) clinical cure-rate over a 3 year follow-up period. Margins of 1 and 2mm are evaluated.

Conditions

Interventions

PROCEDURE

Low-Risk BCC Excisional Margins

After the head and neck basal cell carcinomas satisfy the National Comprehensive clinical and histopathological criteria, all tumors are excised at the 2 mm margin.

Sponsors & Collaborators

  • Advanced Aesthetics

    collaborator UNKNOWN

  • Thomas Jefferson University

    lead OTHER

Principal Investigators

  • Jason B Lee, MD · Jefferson Dermatology Associates

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2017-01-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01903239 on ClinicalTrials.gov